Gene description for NCOA3 |
| Gene name |
nuclear receptor coactivator 3 |
| Gene symbol |
NCOA3 |
| Other names/aliases |
ACTR AIB-1 AIB1 CAGH16 CTG26 KAT13B RAC3 SRC-3 SRC3 TNRC14 TNRC16 TRAM-1 bHLHe42 pCIP |
| Species |
Homo sapiens |
Experiment description of studies that identified NCOA3 in Serum |
| 1
|
| Experiment ID | 975 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà , Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 5 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
| 2
|
| Experiment ID | 976 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà , Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 6 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|